Source: Entourage Health Corp.
  • Entourage Health (ENTG) has expanded its Color Cannabis line with three new premium cannabis products
  • New products include a specialty concentrate, Pedro’s Sweet Sativa Live Sugar, a new pre-roll, Black Sugar Rose, and Space Cake, a new cultivar
  • The new products are now available in Ontario and are expected to expand across Canada throughout the first quarter of 2022
  • Entourage Health is a licence holder producing and distributing cannabis products for both the medical and adult-use markets
  • Shares in Entourage Health Corp. (ENTG) are steady, trading at $0.09 per share

Entourage Health (ENTG) has expanded its Color Cannabis line with three new premium cannabis products.

The new products are now available in Ontario and are expected to expand across Canada throughout the first quarter of 2022.

The first new product, Pedro’s Sweet Sativa Live Sugar, is a new specialty concentrate with 77 to 88 per cent live resin cannabis. The concentrate is hydrocarbon extracted from fresh frozen flower to produce a sugar-in-honey consistency extract.

Entourage has also launched its new pre-roll Black Sugar Rose, which comes in an 18 to 24 per cent THC pack. The pre-roll product, stated the company, is milled directly from the whole flower and conveniently packaged for single-session use.

The final addition to Entourage’s product line is Space Cake, a 20 to 26 per cent THC indica-dominant hybrid that is a rare cross between cultivars Girl Scout Cookies and Snow Lotus.

Space Cake is the first in a series of commercially viable new cultivars coming in 2022.

“Following the recent enhancements to our cultivation programs and success of our in-house growing trials, we are excited to confirm we are broadening into the premium cannabis market with new flower and product formats,” said George Scorsis, Interim CEO and Executive Chair at Entourage.

Retail sales of Entourage’s Color Cannabis brand grew 66 per cent, in 2021, making it one of the company’s top ten performers.

“With our newest additions from Color,” added Mr. Scorsis, “we expect to continue strengthening our portfolio with favoured products throughout 2022 as we launch additional cultivars and products nationwide.”

Entourage Health is a licence holder producing and distributing cannabis products for both the medical and adult-use markets.

Shares in Entourage Health Corp. (ENTG) are steady, trading at $0.09 per share as of 1:07 pm EST.

More From The Market Online
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
File image of a snow drift

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Some shareholders have enjoyed early holiday gifts in the form of rising stock prices, while others have faced disappointments.